Evidence mapPaperPMID 34285392Full record

ReviewNature reviews. Neurology2021

The human connectome in Alzheimer disease - relationship to biomarkers and genetics.

Meichen Yu, Olaf Sporns, Andrew J Saykin

Erratum issuedAbstract readReview
In one paragraph

Review in Nature reviews. Neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 132 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 3 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Effect of online tDCS to left somatomotor cortex on neuropsychiatric symptoms among older adults at risk for dementia.Cortex; a journal devoted to the study of the nervous system and behavior · 2023
    Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Shared spatial and temporal principles govern connectome dynamics across timescales.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Meichen YuIndiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0003-4551-0269
Olaf SpornsIndiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Andrew J SaykinIndiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA. asaykin@iupui.edu.ORCID http://orcid.org/0000-0002-1376-8532

Funding

Project 1U19AG024904 · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · 2025 to 2025
$29.2M
Alzheimer's Disease Neuroimaging InitiativeU01AG024904 · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · 2004 to 2005
$21.3M
INDIANA ALZHEIMERS DISEASE CENTERP30AG010133 · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · 1991 to 2005
$8.8M
Research Education ComponentP30AG072976 · INDIANA UNIVERSITY INDIANAPOLIS · 2025 to 2025
$2.9M
Memory Circuitry in MCI and Early Alzheimer's DiseaseR01AG019771 · DARTMOUTH COLLEGE · 2001 to 2005
$1.9M
Social Networks in Alzheimer Disease 2.0.R37AG057739 · TRUSTEES OF INDIANA UNIVERSITY · 2025 to 2025
$739k
NCI NIH HHS R01 CA129769NIA NIH HHS P30 AG010133NIA NIH HHS P30 AG072976NIA NIH HHS R01 AG019771NIA NIH HHS R01 AG057739NIA NIH HHS R01 AG068193NIA NIH HHS R37 AG057739NIA NIH HHS U01 AG024904NIA NIH HHS U01 AG068057NIA NIH HHS U19 AG024904NLM NIH HHS R01 LM013463
6 · The paper itself

Abstract

The pathology of Alzheimer disease (AD) damages structural and functional brain networks, resulting in cognitive impairment. The results of recent connectomics studies have now linked changes in structural and functional network organization in AD to the patterns of amyloid-β and tau accumulation and spread, providing insights into the neurobiological mechanisms of the disease. In addition, the detection of gene-related connectome changes might aid in the early diagnosis of AD and facilitate the development of personalized therapeutic strategies that are effective at earlier stages of the disease spectrum. In this article, we review studies of the associations between connectome changes and amyloid-β and tau pathologies as well as molecular genetics in different subtypes and stages of AD. We also highlight the utility of connectome-derived computational models for replicating empirical findings and for tracking and predicting the progression of biomarker-indicated AD pathophysiology.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesApolipoproteins EBiomarkersBrainConnectomeHumansNerve NetNeuroimagingAmyloid beta-PeptidesApolipoproteins EBiomarkers

Identifiers

PMID34285392
PMCPMC8403643

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.